[Federal Register Volume 67, Number 160 (Monday, August 19, 2002)]
[Notices]
[Page 53811]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20996]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 19, 2002, and published in the Federal 
Register on March 12, 2002, (67 FR 11141), Chiragene, Inc., Technology 
Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 
08902, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)..................  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
4-Methoxyamphetamine (7411)................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Morphine (9300)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
supply their customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Chiragene, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Chiragene, Inc. on a regular basis to 
ensure that the company's continued registration is consistent with the 
public interest. These investigations have included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: July 29, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-20996 Filed 8-16-02; 8:45 am]
BILLING CODE 4410-09-M